Key result
Telemetric surveillance and new management approaches address the increasing complexity of implanted cardiac devices.
Telemetric device surveillance and novel follow-up strategies are increasingly necessary to manage the growing volume and complexity of implanted cardiac devices.
New HF sensors in complex devices may aid monitoring; leaves open need for outcome trials before practice change.
The number of implanted cardiac devices has dramatically increased in recent years. Moreover, these devices have developed from simple, fixed-rate pacemakers to multi-programmable systems with an ever-increasing amount of information retrievable and programming options available. With the advent of the implantable cardioverter-defibrillators and cardiac resynchronization therapy, devices have become even more complex. New sensors for heart failure monitoring may be expected to make an important impact and at the same time make follow-ups more time consuming. This will increase the demands on follow-up centres, physicians, technologists, and nurses while there is only a limited workforce available due to budgetary restrictions. Therefore, new ways of patient management after cardiac device implantation are needed. This article discusses what new approaches for patient follow-up are currently being developed and investigated in the clinical arena with an emphasis on telemetric device surveillance.
No takes yet. Share an insight, caveat, or question.
Stellbrink et al. (2007) conducted a review in Patients with implanted cardiac devices. Telemetric device surveillance was evaluated. Telemetric device surveillance and new patient management approaches are being developed to address the increasing complexity and follow-up demands of implanted cardiac devices.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: